ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,127Medicare Part D Prescriptions Filled, Including Refills

Rank: 48 out of 633

$500K Total Retail Price of All Prescriptions

Rank: 97 out of 633

479 Patients Receiving at Least One Drug in Part D
88% Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Nebraska
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

4% of this provider’s 479 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 479 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Brand Name Drugs

14% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
SIMVASTATIN 775 764 112 1 3
LEVOTHYROXINE SODIUM 648 603 75 2 1
LISINOPRIL 582 577* 78 3 5
AMLODIPINE BESYLATE 484 469 67 4 4
METOPROLOL SUCCINATE 443 422 53 5 13
ALENDRONATE SODIUM 434 421 47 6 35
FUROSEMIDE 415 399 57 7 6
WARFARIN SODIUM 410 397 46 8 7
METOPROLOL TARTRATE 336 307 52 9 12
OMEPRAZOLE 304 286 52 10 2
ATORVASTATIN CALCIUM 291 267 39 11 9
METFORMIN HCL 270 259 39 12 10
SERTRALINE HCL 250 190 32 13 19
ATENOLOL 244 244 37 14 22
HYDROCHLOROTHIAZIDE 227 222* 35 15 14
POTASSIUM CHLORIDE 221 203 30 16 11
TAMSULOSIN HCL 216 211* 29 17 24
HYDROCODONE-ACETAMINOPHEN 207 170 49 S3 18 8
TRIAMTERENE-HCTZ 137 124 17 19 49
ALPRAZOLAM 126 101 28 B 20 32
BENAZEPRIL HCL 118 106 13 21 50
CRESTOR 115 110* 12 22 27
LOSARTAN POTASSIUM 111 106* 21 23 17
DONEPEZIL HCL 109 109 14 24 33
MIRTAZAPINE 108 103* 14 25 56
LOSARTAN-HYDROCHLOROTHIAZIDE 98 93* 12 26 43
FLUTICASONE PROPIONATE 96 91* 35 27 39
LORAZEPAM 95 90* 19 B 28 37
DIOVAN 95 95 13 28 52
ALLOPURINOL 92 87* 16 30 25
PIOGLITAZONE HCL 89 84* 11 R 31 62
CLOPIDOGREL 89 89 14 31 30
GLIMEPIRIDE 87 87 14 33 38
ADVAIR DISKUS 87 82* 12 33 51
PRAVASTATIN SODIUM 79 79 12 35 21
NAMENDA 78 <11 <11 36 34
POLYETHYLENE GLYCOL 3350 77 63 19 37 29
FENOFIBRATE* 74 <11 <11 38 60
PREDNISONE 70 65* 21 39 36
CARVEDILOL 68 <11 <11 40 18
ENALAPRIL MALEATE 67 <11 <11 41 42
DIGOX 67 <11 <11 41 116
ROPINIROLE HCL 63 <11 <11 43 63
ZOLPIDEM TARTRATE 59 <11 <11 44 26
SYMBICORT 57 <11 <11 45 119
SPIRIVA 57 <11 <11 45 67
PAROXETINE HCL 57 <11 <11 45 74
FLUOXETINE HCL 55 <11 <11 48 78
DILTIAZEM 24HR ER 54 <11 <11 49 112
KLOR-CON M20 54 <11 <11 49 114
PANTOPRAZOLE SODIUM 53 <11 <11 51 28
ENABLEX 53 <11 <11 51 234
TRIAMTERENE-HYDROCHLOROTHIAZID 52 <11 <11 53 137
CLONIDINE HCL 52 <11 <11 53 65
IBANDRONATE SODIUM 52 <11 <11 53 206
ESCITALOPRAM OXALATE 50 <11 <11 56 40
LISINOPRIL-HYDROCHLOROTHIAZIDE 50 <11 <11 56 31
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.